Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$457,252
-$1,110,085 QoQ
Shares Held
51,319
-71.7% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. KYTX ranks #252 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $457,252 51,319
2026-03-31 $1,567,337 181,615
2025-12-31 $1,929,509 205,267
2025-09-30 $794,706 132,451
2025-06-30 $370,192 120,584
2025-03-31 $237,345 122,977
2024-12-31 $679,385 181,654
2024-09-30 $600,756 122,854
2024-06-30 $1,172,220 156,296
2024-03-31 $517,715 20,842